RxDoctor Payments Data

Lauren Riley

Family · Red Bank, NJNPI 1467794685

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.3% of the total across 189 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $968 and has fallen 78.0% since, to $213 in 2025. Among family clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,336in general payments, 2019–2025

Across 189 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$720
  • Sun Pharmaceutical Industries Inc.$672
  • Johnson & Johnson$452
  • Incyte Corporation$343
  • Sanofi$147
  • Lilly USA, LLC$143
  • plus $858 from 15 others

What the payments were for

  • Food & beverage$3,11193%
  • Education$2257%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,336 in reported general payments places this provider in the 90th percentile of 2,692 family providers in New Jersey.

See all family providers in New Jersey →

Medicare billing

Part B allowed, 2024
$38,340
Medicare patients
147
Services billed
658

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate71$6,078
Tacrolimus27$5,866
Clindamycin Phosphate60$2,536
Metronidazole36$2,141
Triamcinolone Acetonide156$1,287
Ketoconazole47$1,094
Fluocinonide28$1,064
Mupirocin73$635
Ammonium Lactate11$351
Hydrocortisone70$321

Paid to pharmacies, not to this prescriber.

Other family in Red Bank

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →